24小时销售热线
18237190368
18237190368
更新时间：2020-05-07 
浏览次数：810奥贝胆酸杂质 全套对照品
深圳艾利蒙生物科技有限公司可提供奥贝胆酸杂质全套，并随货提供COA证书，HPLC，NMR，MS图谱，10mg/25mg/50mg/100mg等多种规格可选。
部分杂质长期备有现货，可快速发货，并可根据客户需要提供杂质定制服务。
奥贝胆酸的相关介绍：
适应症：
PBC又称为原发性胆汁性胆管炎，是一种慢性进展性自身免疫性肝病，会导致肝硬化或肝瘢痕。随着肝硬化的发展，肝脏瘢痕组织的数量增加，肝功能衰竭，需要进行肝脏移植。PBC用药周期长，甚至需要终生用药。
奥贝胆酸已被证明对治疗非酒精性脂肪性肝炎(NASH)有效，美国FDA已授予其突破性疗法认定。
奥贝胆酸是肝脏和小肠表达的核受体激动剂，临床上主要是应用于目前临床药物不应答或者不耐受，并有很大风险的导致肝移植、肝硬化或者死亡的原发性胆汁性胆管炎的患者。
奥贝胆酸杂质 全套对照品
奥贝胆酸杂质为我司优势杂质，长期备有库存，发货快。杂质结构式及更多其他杂质对照品，可进入我公司展台详细查看。
附：奥贝胆酸杂质列表：
中文名称 | 英文名称 | CAS号 |
奥贝胆酸标准品 | Obeticholic Acid | 459789-99-2 |
奥贝胆酸杂质1 | (R)-4-((3R,5S,6R,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 865244-30-0 |
奥贝胆酸杂质2 | (R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 915038-26-5 |
奥贝胆酸杂质3 | (R)-4-((3R,5S,6S,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 915038-27-6 |
奥贝胆酸杂质4 | (R)-4-((3R,5R,7S,8S,9S,10R,13R,14S,17R)-6-ethylidene-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
|
奥贝胆酸杂质5 | (R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 474-25-9 |
奥贝胆酸杂质6 | (R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-((((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)oxy)methyl)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
|
奥贝胆酸杂质7 | (R)-4-((3R,5S,6S,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 1708092-13-0 |
奥贝胆酸杂质8 | (3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 1537866-49-1 |
奥贝胆酸杂质9 | (R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 4651-67-6 |
奥贝胆酸杂质10 | (R)-methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | 10538-59-7 |
奥贝胆酸杂质11 | (R)-methyl 4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate |
|
奥贝胆酸杂质12 | (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 915038-24-3 |
奥贝胆酸杂质13 | (R)-4-((3R,5S,6S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
|
奥贝胆酸杂质14 | (4R)-4-((3R,5S,6R,7R,9S,10S,13R,14S,17R)-6-ethyl-3-(((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | 1908444-28-9 |
奥贝胆酸杂质15 | (R)-4-((3R,5R,7S,8S,9S,10R,13R,14S,17R,E)-6-ethylidene-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
|
奥贝胆酸杂质16 | (R)-4-((5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
|
奥贝胆酸杂质17 | (R)-methyl 4-((3R,5R,8S,9S,10R,13R,14S,17R,Z)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | 863239-59-2 |
深圳艾利蒙生物科技有限公司主营医药标准品及杂质对照品，所有杂质均提供HPLC，NMR，MS图谱及CoA证： 舒更葡糖钠杂质，骨化三醇杂质，阿法骨化醇杂质，艾地骨化醇杂质，西格列汀杂质，利伐沙班杂质，依托考昔杂质，左氧氟沙星杂质，阿加曲班杂质，利奈唑胺杂质，匹伐他汀杂质，利格列汀杂质，替格瑞洛杂质，阿哌沙班杂质，西他沙星杂质，伊马替尼杂质，洛索洛芬钠杂质，普瑞巴林杂质，环苯扎林杂质，盐酸帕洛诺司琼杂质等。
技术文章
我的位置：